BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2665032)

  • 1. Review of cardiovascular findings in humans treated with minoxidil.
    Sobota JT
    Toxicol Pathol; 1989; 17(1 Pt 2):193-202. PubMed ID: 2665032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular toxicity of minoxidil in the marmoset.
    Hanton G; Sobry C; Daguès N; Rochefort GY; Bonnet P; Eder V
    Toxicol Lett; 2008 Aug; 180(3):157-65. PubMed ID: 18582543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of cardiovascular alterations in dogs treated with minoxidil.
    Mesfin GM; Piper RC; DuCharme DW; Carlson RG; Humphrey SJ; Zins GR
    Toxicol Pathol; 1989; 17(1 Pt 2):164-81. PubMed ID: 2568681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of M-mode and Doppler echocardiography to investigate the cardiotoxicity of minoxidil in beagle dogs.
    Hanton G; Gautier M; Bonnet P
    Arch Toxicol; 2004 Jan; 78(1):40-8. PubMed ID: 12937890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of minoxidil-induced acute cardiotoxicity in miniature swine.
    Herman EH; Ferrans VJ; Young RS; Balazs T
    Toxicology; 1988 Jan; 48(1):41-51. PubMed ID: 3336882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional consequences of minoxidil-induced cardiac hypertrophy.
    Moravec CS; Ruhe T; Cifani JR; Milovanovic M; Khairallah PA
    J Pharmacol Exp Ther; 1994 Apr; 269(1):290-6. PubMed ID: 8169836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of minoxidil-induced myocardial lesions in beagle dogs and miniature swine.
    Herman EH; Ferrans VJ; Young RS; Balazs T
    Toxicol Pathol; 1989; 17(1 Pt 2):182-92. PubMed ID: 2749140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac morphologic alterations in acute minoxidil cardiotoxicity in miniature swine.
    Van Vleet JF; Herman EH; Ferrans VJ
    Exp Mol Pathol; 1984 Aug; 41(1):10-25. PubMed ID: 6468630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous and induced arterial disease in the dog: pathology and pathogenesis.
    Detweiler DK
    Toxicol Pathol; 1989; 17(1 Pt 2):94-108. PubMed ID: 2665038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacologic basis of the cardiovascular toxicity of minoxidil in the dog.
    Mesfin GM; Robinson FG; Higgins MJ; Zhong WZ; DuCharme DW
    Toxicol Pathol; 1995; 23(4):498-506. PubMed ID: 7501961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the effect of chronic oral administration of minoxidil and hydralazine on vascular function in spontaneously hypertensive rats.
    Greeberg S
    J Pharmacol Exp Ther; 1980 Nov; 215(2):279-86. PubMed ID: 7441494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectivity versus toxicity of minoxidil as antiproliferative agent for lens epithelial cells. In vitro study].
    Hernández-Galilea E; Barahona JM; Vázquez R; Castro R; Urrutia M; Sánchez F
    Arch Soc Esp Oftalmol; 2002 Jul; 77(7):361-8. PubMed ID: 12098807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pericardial effusion associated with minoxidil therapy.
    Houston MC; McChesney JA; Chatterjee K
    Arch Intern Med; 1981 Jan; 141(1):69-71. PubMed ID: 7447585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotoxicity of hydralazine and minoxidil in the rat. Influence of age.
    Hanton G; Longeart L; Lodola A
    Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):231-4. PubMed ID: 2047568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of dihydralazine diazoxide and minoxidil alone or associated with propranolol in renal hypertensive rats.
    Provost Y; Lindenbaum A; Cohen Y; Wepierre J
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):103-15. PubMed ID: 7259363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical use of minoxidil in children and systemic side effects.
    Georgala S; Befon A; Maniatopoulou E; Georgala C
    Dermatology; 2007; 214(1):101-2. PubMed ID: 17191059
    [No Abstract]   [Full Text] [Related]  

  • 17. Minoxidil topical solution: an unsafe product for children.
    Claudet I; Cortey C; Honorat R; Franchitto N
    Pediatr Emerg Care; 2015 Jan; 31(1):44-6. PubMed ID: 25426682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echocardiography, a non-invasive method for the investigation of heart morphology and function in laboratory dogs: 2. Effects of minoxidil and quinidine on the left ventricle function.
    Hanton G; Lodola A
    Lab Anim; 1998 Apr; 32(2):183-90. PubMed ID: 9587901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minoxidil in the treatment of refractory hypertension.
    Rosenthal T; Swartz J; Teicher A; Boichis H
    Angiology; 1980 Mar; 31(3):176-84. PubMed ID: 6989293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium channel openers increase aortic elastic fiber formation and reverse the genetically determined elastin deficit in the BN rat.
    Slove S; Lannoy M; Behmoaras J; Pezet M; Sloboda N; Lacolley P; Escoubet B; Buján J; Jacob MP
    Hypertension; 2013 Oct; 62(4):794-801. PubMed ID: 23918751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.